The neuroprotective activities of melatonin against the Alzheimer β-protein are not mediated by melatonin membrane receptors

Journal of Pineal Research

Volumn 32, Issue 3, 2002, Pages 135-142

  Pappolla, Miguel A ^a   Simovich, Marcia J ^a   Bryant Thomas, Tara ^a   Chyan, Yau Jan ^a   Poeggeler, Burkhard ^a   Dubocovich, Margarita ^b   Bick, Roger ^c   Perry, George ^d   Cruz Sanchez, Felix ^e   Smith, Mark A ^d  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e UNIVERSITAT INTERNACIONAL DE CATALUNYA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; FREE RADICAL; MELATONIN; MELATONIN RECEPTOR; N TERT BUTYL ALPHA PHENYLNITRONE;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DEATH; HIPPOCAMPUS; HOMEOSTASIS; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; OXIDATIVE STRESS; RECEPTOR BINDING;

5-METHOXYTRYPTAMINE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIOXIDANTS; CELLS, CULTURED; FREE RADICAL SCAVENGERS; HIPPOCAMPUS; HUMANS; MELATONIN; NEUROBLASTOMA; NEURONS; NEUROPROTECTIVE AGENTS; NITROGEN OXIDES; RATS; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, MELATONIN; SEROTONIN;

EID: 0036227676     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-079x.2002.1o838.x     Document Type: Article

References (62)

1. Melatonin, mitochondria, and cellular bioenergetics
2. Pathological implications of nitric oxide superoxide and peroxynitrite formation
3. Hydrogen peroxide mediates amyloid β protein toxicity
4. The amyloid β protein induces oxidative damage of mitochondrial DNA
5. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination
6. Potent neuroprotective properties against the Alzhimer b-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid
7. Dexamethasone-induced thymocyte apoptosis: Apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases
8. Apoptosis decision cascades and neuronal degeneration in Alzheimer's Disease
9. Dissociation of apoptosis from proliferation, protein kinase B activation, and BAD phosphorylation in interleukin-3-mediated phosphoinositide 3-kinase signaling
10. Cerebrovascular hypoperfusion: A risk factor for Alzheimer's disease? Animal model and postmortem human studies
11. D1-dopamine receptor abnormality in frontal cortex points to a functional alteration of cortical cell membranes in Alzheimer's disease
12. Chrono-neuroendocrinological aspects of physiological aging and senile dementia
13. Neuroanatomically selective down-regulation of beta adrenergic receptors by chronic 545 pramine treatment: Relationships to the topography of [3H] imipramine and [3H] desipramine binding sites
14. Characteristics and autoradiographic localization of 2-[1251]iodomelatonin binding sites in Djungarian hamster brain
15. Aging and dementia chapter
16. Localization of superoxide dismutases in Alzheimer's disease and Down syndrome neocortex and hippocampus
17. Signal transduction for melatonin in human lymphocytes: Involvement of a pertussis toxin-sensitive G protein
18. Evidence for neuronal oxidative damage in Alzheimer's disease
19. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill
20. Age-dependent reduction in serum melatonin concentrations in healthy subjects
21. Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging Alzheimer's disease and apolipoprotein E-ε4/4 genotype
22. 2+ homeostasis and cell death
23. Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress
24. Excitatory amino acids growth factors and calcium: A teeter-totter model for neural plasticity and degeneration
25. Excitatory amino acids, growth factors and calcium: A teeter-totter model for neural plasticity and degeneration
26. β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity
27. Membrane disruption by Alzheimer beta-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for Neurotoxicity
28. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease
29. Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia
30. 4-hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease
31. The superoxide-generating oxidase of phagocytic cells. Physiological, molecular and pathological aspects
32. Melatonin effects on inhibition of thirst and lever induced by lipopolysaccharide in rat
33. Alzheimer's disease: A re-examination of the amyloid hypothesis
34. Immunohistochemical evidence of oxidative stress in Alzheimer's disease
35. The genesis of the senile plaque. Further evidence in support of its neuronal origin
36. Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer's amyloid peptide
37. Inhibition of Alzheimer β-fibrillogenesis by melatonin
38. Aβ mediated oxidative damage of mitochondrial DNA: Prevention by melatonin
39. The pineal gland: Circadian or seasonal aging clock?
40. The pineal control of aging. The effects of melatonin and pineal grafting on the survival of older mice
41. Melatonin and structurally-related endogenous indoles act as potent electron donors and radical scavengers in vitro
42. Melatonin receptor-mediated stimulation of phosphoinositide breakdown in chick brain slices
43. Oxidative damage in the central nervous system: Protection by melatonin
44. Antioxidant capacity of melatonin: A novel function not requiring a receptor
45. Melatonin: Mechanisms and actions as an antioxidant
46. Actions of melatonin in the reduction of oxidative stress: A review
47. Cloning of a structural and functional homolog of the circadian clock gene period from the giant silkmoth Antheraea pernyi
48. A novel interaction between inhibitory melatonin receptors and protein kinase C-dependent signal transduction in bovine pars tuberalis cells
49. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease
50. Early contribution of oxidative glycation in Alzheimer disease
51. Widespread peroxynitrite-mediated damage in Alzheimer's disease
52. Death by design: Mechanism and control of apoptosis
53. Fibrillogenesis of synthetic amyloid-beta peptides is dependent on their initial secondary structure
54. Abnormal melatonin response to 5-methoxypsoralen in dementia
55. Possible mediation of quinolinic acid-induced hippocampal damage by reactive oxygen species
56. Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro
57. Melatonin: A potent endogenous hydroxyl radical scavenger
58. Hypothalamic melatonin receptor sites revealed by autoradiography
59. Methionine residue 35 is important in amyloid beta-peptide-associated free radical oxidative stress
60. Localization and characterization of melatonin receptors in rodent brain by in vitro autoradiography
61. Melatonin-binding sites in the rat brain and pituitary mapped by in-vitro autoradiography
62. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease